Press Releases

Normal neuronal firing may spark brain tumor growth

Tuesday, June 16, 2015
NIH-funded study opens new path to discovering brain cancer treatments

NIH Names Walter J. Koroshetz, M.D. Director of the National Institute of Neurological Disorders and Stroke

Thursday, June 11, 2015
National Institutes of Health Director Francis S. Collins, M.D., Ph.D. announced today the selection of Walter J. Koroshetz, M.D., as the Director of the National Institute of Neurological Disorders and Stroke (NINDS).  He has served as Acting Director of the NINDS since October, 2014. 

Scientists create mice with a major genetic cause of ALS and FTD

Friday, May 22, 2015
NIH-funded study provides new platform for testing treatments for several neurodegenerative disorders

A SMARTer approach to stroke care

Wednesday, May 13, 2015
NIH study uses MRI scans to screen stroke patients for acute treatment within the first critical 60 minutes

Scientists unravel the mystery of the tubulin code

Tuesday, May 12, 2015
NIH study provides a glimpse into the code that controls variety of cell functions

Study points to possible treatment for lethal pediatric brain cancer

Monday, May 4, 2015
NIH-funded preclinical study suggests epigenetic drugs may be used to treat leading cause of pediatric brain cancer death

Drugs that activate brain stem cells may reverse multiple sclerosis in mice

Monday, April 20, 2015
NIH-funded study identifies over-the-counter compounds that may replace damaged cells

Strengthening the immune system’s fight against brain cancer

Wednesday, March 18, 2015
NIH-funded research suggests novel way to improve vaccine efficacy in brain tumors
This image compares sections of cortex from a control mouse (left) to a mouse with a presenilin-1 mutation (right). The dashed line indicates the surface of the brain. Presenilin-1 mutations decrease gamma-secretase activity and cause features of neurodeg

Study reveals how genetic changes lead to familial Alzheimer’s disease

Wednesday, March 11, 2015
NIH-funded research suggests novel approach for developing drugs for inherited Alzheimer’s

Pages